Lobbying client
MOLECULAR INSIGHT PHARMACEUTICALS
Biopharmaceutical Company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
11
Filed by
2
Reported in-house
—
Reported by firms
$200,750
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2007 to 2010
Filings
3 filings for 2009, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Amendment 4th Quarter 2009
|
O'NEILL AND ASSOCIATES | $30,000 reported |
|
4th Quarter - Reportreplaced 4th Quarter 2009
|
O'NEILL AND ASSOCIATES | $30,000 reported |
|
Registration 2nd Quarter 2009
|
O'NEILL AND ASSOCIATES | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| JEFFREY J. KIMBELL & ASSOCIATES, INC. | 6 | $150,750 |
| O'NEILL AND ASSOCIATES | 2 | $50,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 4 |
| Budget/Appropriations | BUD | 2 |
| Pharmacy | PHA | 2 |
| Science/Technology | SCI | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.